GSA CAPITAL PARTNERS LLP - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 131 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$304,000
+38.2%
16,096
-13.8%
0.04%
+64.0%
Q2 2019$220,000
+41.0%
18,681
+63.9%
0.02%
+56.2%
Q1 2019$156,000
-44.7%
11,398
+32.2%
0.02%
+14.3%
Q3 2015$282,000
-6.6%
8,622
+51.3%
0.01%
+16.7%
Q2 2015$302,000
+43.8%
5,700
-21.7%
0.01%
+50.0%
Q1 2015$210,0007,2800.01%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,628,328$33,869,00014.72%
Foresite Capital Management II, LLC 995,396$20,704,00010.39%
Cormorant Asset Management, LP 1,581,604$32,897,0004.43%
DAFNA Capital Management LLC 221,013$4,597,0004.04%
New Leaf Venture Partners, L.L.C. 228,428$4,751,0003.40%
Partner Investment Management, L.P. 63,571$1,322,0001.75%
Iguana Healthcare Management, LLC 140,000$2,912,0001.74%
PFM Health Sciences, LP 2,913,951$60,610,0001.71%
Redmile Group, LLC 920,550$19,147,0001.65%
SECTORAL ASSET MANAGEMENT INC 669,351$13,923,0001.54%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders